Pharmaceutical companies face unique challenges: protecting intellectual property, ensuring patient data privacy, and meeting strict global regulations. Our Identity & Access Management (IAM) practice helps pharma organizations secure their digital ecosystem while enabling innovation and collaboration across research, manufacturing, and distribution.
We specialize in IAM strategies that address the unique challenges of financial institutions:

Protect proprietary drug formulas and clinical trial data

Align with FDA 21 CFR Part 11, HIPAA, GDPR, and SOX

Secure access for CROs, regulators, and global research teams

Control access across manufacturing and distribution networks

Secure cloud-based lab systems and digital health platforms
Challenge: Researchers, CROs, and regulators need controlled access to sensitive trial data
Solution: Role-based and attribute-based access controls
Outcome: Reduced data leaks, faster trial approvals, FDA/EMA compliance
Challenge: Drug formulas and R&D data are prime targets for cyberattacks
Solution: Privileged Access Management (PAM) and least privilege enforcement
Outcome: Stronger IP protection, reduced insider threats
Challenge: Demonstrating compliance with strict regulations
Solution: Access certification campaigns and audit trail management
Outcome: Streamlined audits, reduced compliance costs
Challenge: Vendors and distributors need temporary, secure access
Solution: Identity federation and access governance
Outcome: Efficient supply chain, reduced unauthorized access
Challenge: Managing patient data through digital platforms
Solution: Strong authentication, encryption, and monitoring
Outcome: HIPAA/GDPR compliance, enhanced patient trust
Stronger compliance posture across global regulations
Streamlined collaboration with external partners and regulators
Reduced risk of IP theft and
data breaches
Faster time-to-market for new drugs and therapies
Increased trust among patients, regulators, and
stakeholders
We combine deep IAM expertise with pharma-specific insight. Our consultants understand the balance between security, compliance, and innovation, helping pharmaceutical companies protect their most valuable assets while accelerating growth.